TNF and inflammatory bowel disease: It is interesting to highlight that treatment with antitumor necrosis factor-alpha agents has been shown to improve iron deficiency by improving erythropoiesis, implicating a role for TNF-alpha in development of ACD and/or IDA in IBD patients [13].